Skip to main content
Premium Trial:

Request an Annual Quote

Phase Genomics Wins $200K Grant to Develop Microbiome Discovery Tech

NEW YORK (GenomeWeb) — Phase Genomics said today that it has received a $200,000 grant from the Bill & Melinda Gates Foundation to develop a computational platform for extracting genomic information from microbiome samples.

Seattle-based Phase offers research services and kits based on its Hi-C and proximity-ligation technologies, which enable chromosome-scale genome assembly, metagenomic deconvolution, and the analysis of structural genomic variation and genome architecture.

With the one-year grant, the company said it will develop a platform to identify species and strains of bacteria that cannot be cultured or detected with standard methods. Applications include the discovery of new gut microbes and the ways they colonize mother and child.

"By collaborating with Phase Genomics on the development of metagenomic proximity-ligation technology, we hope to increase our understanding of the microbes that impact human health, with a focus on understudied samples from the developing world," Stanford University researcher and Phase collaborator Justin Sonnenburg said in a statement. "Our goal is to produce a tool that will make the highest resolution microbiome analysis accessible to researchers around the globe."

In mid-2018, Phase was awarded a two-year, $1.5 million grant from the National Institutes of Health to develop an affordable, high-throughput Hi-C kit and computational analysis platform for microbiome research and discovery.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.